US FDA Clarifies: Coronavirus Vaccine Will Need Adcom Before Approval Decision

 
• By Derrick Gingery

In a JAMA article, senior FDA leaders state that the outside advisers will be needed to ensure transparency given the potentially widespread use of the vaccine.

FDA Advisory Committee Feature image
The JAMA article was published after FDA and other administration officials made less than definitive statements about whether an advisory committee would be convened.

More from US FDA Performance Tracker

More from Regulatory Trackers